Data / Drug companies / Dextromethorphan polistirex
Dextromethorphan polistirex: 27 companies and 64 products in the FDA NDC directory
Dextromethorphan polistirex is listed in the FDA National Drug Code Directory by 27 companies, with 64 products in commercial distribution. 64 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are suspension; suspension, extended release, and the newest product started marketing on October 7, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 27
- Products
- 64
- Generic (ANDA) products
- 64 (100.0%)
- Application numbers
- 3
- Routes
- Oral
- Brand names
- Cough DM, Cough DM, Robitussin 12 Hour Cough Relief, Basic Care Childrens Cough DM, Leader Cough DM, CareOne Cough DM, Foster and Thrive 12 Hour Cough Relief, Childrens Robitussin 12 Hour Cough Relief
- openFDA record search
- api.fda.gov
Companies that list dextromethorphan polistirex
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Amazon.com Services LLC | 6 | suspension; suspension, extended release | Generic drugs (ANDA) | August 20, 2026 |
| Haleon US Holdings LLC | 6 | suspension, extended release | Generic drugs (ANDA) | July 5, 2016 |
| Aurohealth LLC | 4 | suspension, extended release | Generic drugs (ANDA) | April 17, 2026 |
| Meijer Distribution Inc | 4 | suspension; suspension, extended release | Generic drugs (ANDA) | March 26, 2015 |
| Safeway | 4 | suspension; suspension, extended release | Generic drugs (ANDA) | May 4, 2026 |
| CVS Pharmacy | 3 | suspension; suspension, extended release | Generic drugs (ANDA) | March 27, 2015 |
| CVS Woonsocket Prescription Center, Incorporated | 3 | suspension; suspension, extended release | Generic drugs (ANDA) | June 1, 2026 |
| Cardinal Health 110, LLC. DBA Leader | 3 | suspension; suspension, extended release | Generic drugs (ANDA) | June 6, 2017 |
| Walgreen Company | 3 | suspension; suspension, extended release | Generic drugs (ANDA) | July 1, 2015 |
| American Sales Company | 2 | suspension | Generic drugs (ANDA) | August 23, 2013 |
| Amneal Pharmaceuticals LLC | 2 | suspension | Generic drugs (ANDA) | August 1, 2017 |
| Dolgencorp, Inc. (dollar General & Rexall) | 2 | suspension | Generic drugs (ANDA) | July 10, 2013 |
| HyVee Inc | 2 | suspension, extended release; suspension | Generic drugs (ANDA) | May 18, 2015 |
| Kroger Company | 2 | suspension; suspension, extended release | Generic drugs (ANDA) | June 28, 2018 |
| L. Perrigo Company | 2 | suspension | Generic drugs (ANDA) | June 20, 2013 |
| Strategic Sourcing Services LLC | 2 | suspension, extended release; suspension | Generic drugs (ANDA) | October 4, 2023 |
| Target Corporation | 2 | suspension; suspension, extended release | Generic drugs (ANDA) | October 7, 2026 |
| Topco Associates LLC | 2 | suspension; suspension, extended release | Generic drugs (ANDA) | July 30, 2015 |
| Wal-Mart Stores Inc | 2 | suspension | Generic drugs (ANDA) | July 21, 2015 |
| Amerisource Bergen | 1 | suspension | Generic drugs (ANDA) | August 30, 2012 |
| Atlantic Biologicals Corp. | 1 | suspension | Generic drugs (ANDA) | September 6, 2012 |
| Bryant Ranch Prepack | 1 | suspension | Generic drugs (ANDA) | September 10, 2012 |
| H E B | 1 | suspension | Generic drugs (ANDA) | August 30, 2012 |
| Major Pharmaceuticals | 1 | suspension | Generic drugs (ANDA) | September 6, 2012 |
| Padagis Israel Pharmaceuticals Ltd | 1 | suspension | Generic drugs (ANDA) | September 10, 2012 |
| Publix Super Markets Inc | 1 | suspension | Generic drugs (ANDA) | February 25, 2014 |
| United Natural Foods, Inc. DBA Unfi | 1 | suspension | Generic drugs (ANDA) | October 19, 2012 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Suspension | 41 | 64.1% |
| Suspension, extended release | 23 | 35.9% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 64 | 100% |
Pharmacologic classes
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.